ConductScience.org, home

Paper8391069

An experimental model of retrovirus gene therapy for malignant brain tumors.

Takamiya Y and 6 others. J Neurosurg, 1993. Cited by 141 papers, by iCite.

Cite this record

ConductScience Library. An experimental model of retrovirus gene therapy for malignant brain tumors. Papers, record 8391069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8391069

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An experimental model of retrovirus gene therapy for malignant brain tumors.
PubMed
Journal
J Neurosurg
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
141
iCite
Relative citation ratio, by iCite
3.5
iCite
Revised in PubMed
2013-11-21
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Takamiya YY
2Short MPM P
3Moolten FLF L
4Fleet CC
5Mineta TT
6Breakefield XOX O
7Martuza RLR L

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain NeoplasmsMajor topic
GanciclovirMajor topic
Genetic TherapyMajor topic
GliomaMajor topic
RetroviridaeMajor topic
Animals
Dose-Response Relationship, Drug
Drug Resistance
Mice
Mice, Nude
Moloney murine leukemia virus
Simplexvirus
Thymidine Kinase
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CIDA KO8012151NCPDCID CDC HHSUnited StatesPubMedPubMed
NS24279NINDS NIH HHSUnited StatesP01NS024279PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 141 citations.

PMIDTitleJournalYearIn PapersSource
40113830Germ cell depletion using HSV-TK in mouse testes.Sci Rep2025https://conductscience.org/library/papers/40113830PubMed
21453286Gene therapy and targeted toxins for glioma.Curr Gene Ther2011https://conductscience.org/library/papers/21453286PubMed
20811580Herpes simplex virus type 1/adeno-associated virus hybrid vectors.Open Virol J2010https://conductscience.org/library/papers/20811580PubMed
16457645Gene therapy and targeted toxins for glioma.Curr Gene Ther2005https://conductscience.org/library/papers/16457645PubMed
14682378Adenovirus/herpes simplex-thymidine kinase/ganciclovir complex: preliminary results of a phase I trial in patients with recurrent malignant gliomas.J Neurooncol2003https://conductscience.org/library/papers/14682378PubMed
12489026Replicative retroviral vectors for cancer gene therapy.Cancer Gene Ther2003https://conductscience.org/library/papers/12489026PubMed
11857036Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy.Cancer Gene Ther2002https://conductscience.org/library/papers/11857036PubMed
11313821Generation of high-titer retroviral vector-producing macrophages as vehicles for in vivo gene transfer.Gene Ther2001https://conductscience.org/library/papers/11313821PubMed
11238837Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues.J Virol2001https://conductscience.org/library/papers/11238837PubMed
10476214Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene.Gene Ther1999https://conductscience.org/library/papers/10476214PubMed
10467366Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant.Gene Ther1999https://conductscience.org/library/papers/10467366PubMed
10457334G207, modified herpes simplex virus type 1, kills human pancreatic cancer cells in vitro.J Gastrointest Surg1999https://conductscience.org/library/papers/10457334PubMed
10455405Therapeutic efficacy of the thymidine kinase/ganciclovir system on large experimental gliomas: a nuclear magnetic resonance imaging study.Gene Ther1999https://conductscience.org/library/papers/10455405PubMed
95241005-Fluorocytosine-mediated apoptosis and DNA damage in glioma cells engineered to express cytosine deaminase and their enhancement with interferon.J Neurooncol1998https://conductscience.org/library/papers/9524100PubMed
9049851Anti-tumor gene therapy.J Neurooncol1997https://conductscience.org/library/papers/9049851PubMed
9034632An in vitro nucleoside analog screening method for cancer gene therapy.Cell Biol Toxicol1996https://conductscience.org/library/papers/9034632PubMed
8943097Preservation of the bystander cytocidal effect of irradiated herpes simplex virus thymidine kinase (HSV-tk) modified tumor cells.J Neurooncol1996https://conductscience.org/library/papers/8943097PubMed
8876132The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8876132PubMed
7975564Gene therapy for diseases of the nervous system.West J Med1994https://conductscience.org/library/papers/7975564PubMed
7877992Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma.Proc Natl Acad Sci U S A1995https://conductscience.org/library/papers/7877992PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8391069

GET https://conductscience.org/api/papers/v1/8391069/cited_by?page=2